Rajagopalan S, Long E O
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, USA.
J Exp Med. 1997 Apr 21;185(8):1523-8. doi: 10.1084/jem.185.8.1523.
Natural killer (NK) cells in mice and humans express a number of structurally diverse receptors that inhibit target cell lysis upon recognition of major histocompatibility complex (MHC) class I molecules expressed on targets. The contribution of peptide to the structural features of class I required for NK cell inhibition appears to vary depending on the type of receptor engaged. Thus, while there is no peptide specificity in NK inhibition mediated by Ly-49A in the mouse, human histocompatibility antigen (HLA)-B*2705-specific NK clones displayed selectivity for peptides. In this report, we examine the role of peptide in the recognition of HLA-C by the defined killer cell inhibitory receptor (KIR) cl42 with established specificity for HLA-Cw4. Binding of soluble KIR cl42 molecules to HLA-Cw4 expressed on transporter associated with antigen presentation (TAP)-deficient RMA-S cells occurred only upon exogenous peptide loading. Moreover, there was peptide selectivity in that certain substitutions at positions 7 and 8 of the nonamer peptide QYDDAVYKL abolished Cw4 interaction with KIR cl42 despite similar surface expression of HLA-C. The specificity of this direct interaction between peptide-loaded HLA-Cw4 on RMA-S cells and soluble KIR cl42 correlated with recognition by NK clones in that they were inhibited only by HLA-Cw4 loaded with the appropriate peptides.
小鼠和人类的自然杀伤(NK)细胞表达多种结构各异的受体,这些受体在识别靶细胞上表达的主要组织相容性复合体(MHC)I类分子后会抑制靶细胞裂解。肽对NK细胞抑制所需的I类分子结构特征的贡献似乎因所涉及的受体类型而异。因此,虽然小鼠中由Ly-49A介导的NK抑制没有肽特异性,但人类组织相容性抗原(HLA)-B*2705特异性NK克隆对肽具有选择性。在本报告中,我们研究了肽在具有既定的HLA-Cw4特异性的确定杀伤细胞抑制受体(KIR)cl42识别HLA-C中的作用。可溶性KIR cl42分子与在与抗原呈递相关的转运体(TAP)缺陷的RMA-S细胞上表达的HLA-Cw4的结合仅在外源肽加载后发生。此外,存在肽选择性,因为九肽QYDDAVYKL的第7和8位的某些取代消除了Cw4与KIR cl42的相互作用,尽管HLA-C的表面表达相似。RMA-S细胞上负载肽的HLA-Cw4与可溶性KIR cl42之间这种直接相互作用的特异性与NK克隆的识别相关,因为它们仅被负载适当肽的HLA-Cw4抑制。